Education
About Us
Working with TipRanks
Follow Us
Ajanta Pharma Limited (IN:AJANTPHARM)
:AJANTPHARM
Total Valuation
Ajanta Pharma Limited has a market cap or net worth of ₹321.74B. The enterprise value is ―.
Market Cap₹321.74B
Enterprise Value―
Share Statistics
Ajanta Pharma Limited has 124,912,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding124,912,100
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Ajanta Pharma Limited’s return on equity (ROE) is 0.23 and return on invested capital (ROIC) is 38.40%.
Return on Equity (ROE)0.23
Return on Assets (ROA)0.18
Return on Invested Capital (ROIC)38.40%
Return on Capital Employed (ROCE)0.53
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.91
Inventory Turnover1.35
Valuation Ratios
The current PE Ratio of Ajanta Pharma Limited is 34.54. Ajanta Pharma Limited’s PEG ratio is 13.02.
PE Ratio34.54
PS Ratio0.00
PB Ratio8.77
Price to Fair Value7.90
Price to FCF236.78
Price to Operating Cash Flow237.33
PEG Ratio13.02
Income Statement
In the last 12 months, Ajanta Pharma Limited had revenue of 42.09B and earned 8.16B in profits. Earnings per share was 64.82.
Revenue42.09B
Gross Profit30.93B
Operating Income19.68B
Pretax Income11.14B
Net Income8.16B
EBITDA12.57B
Earnings Per Share (EPS)64.82
Cash Flow
In the last 12 months, operating cash flow was 1.36B and capital expenditures 0.00, giving a free cash flow of 1.36B billion.
Operating Cash Flow1.36B
Free Cash Flow1.36B
Free Cash Flow per Share10.88
Dividends & Yields
Ajanta Pharma Limited pays an annual dividend of ₹28, resulting in a dividend yield of 2.1%
Dividend Per Share₹28
Dividend Yield2.1%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.27
52-Week Price Change10.51%
50-Day Moving Average2.60K
200-Day Moving Average2.84K
Relative Strength Index (RSI)57.11
Average Volume (3m)2.60K
Important Dates
Ajanta Pharma Limited upcoming earnings date is Jul 24, 2025, TBA Not Confirmed.
Last Earnings DateApr 30, 2025
Next Earnings DateJul 24, 2025
Ex-Dividend DateNov 06, 2024
Financial Position
Ajanta Pharma Limited as a current ratio of 3.05, with Debt / Equity ratio of 0.89%
Current Ratio3.05
Quick Ratio2.12
Debt to Market Cap<0.01
Net Debt to EBITDA-0.07
Interest Coverage Ratio272.92
Taxes
In the past 12 months, Ajanta Pharma Limited has paid 2.98B in taxes.
Income Tax2.98B
Effective Tax Rate0.27
Enterprise Valuation
Ajanta Pharma Limited EV to EBITDA ratio is 22.36, with an EV/FCF ratio of 44.40.
EV to Sales6.68
EV to EBITDA22.36
EV to Free Cash Flow44.40
EV to Operating Cash Flow35.78
Balance Sheet
Ajanta Pharma Limited has ₹4.60B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹4.60B billion.
Cash & Marketable Securities₹4.60B
Total Debt₹0.00
Net Cash-₹4.60B
Net Cash Per Share-₹36.79
Tangible Book Value Per Share₹282.15
Margins
Gross margin is 63.87%, with operating margin of 46.75%, and net profit margin of 19.39%.
Gross Margin63.87%
Operating Margin46.75%
Pretax Margin26.47%
Net Profit Margin19.39%
EBITDA Margin29.86%
EBIT Margin26.64%
Analyst Forecast
The average price target for Ajanta Pharma Limited is ₹3,140.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹3,140.00
Price Target Upside16.26% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―